SE9700244D0 - Novel antibacterial protein - Google Patents

Novel antibacterial protein

Info

Publication number
SE9700244D0
SE9700244D0 SE9700244A SE9700244A SE9700244D0 SE 9700244 D0 SE9700244 D0 SE 9700244D0 SE 9700244 A SE9700244 A SE 9700244A SE 9700244 A SE9700244 A SE 9700244A SE 9700244 D0 SE9700244 D0 SE 9700244D0
Authority
SE
Sweden
Prior art keywords
gloverin
relates
novel antibacterial
antibacterial protein
pharmaceutically active
Prior art date
Application number
SE9700244A
Other languages
English (en)
Other versions
SE519350C2 (sv
Inventor
Anette Carlsson
Andreas Axen
Aake Engstroem
Hans Bennich
Original Assignee
Anette Carlsson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anette Carlsson filed Critical Anette Carlsson
Priority to SE9700244A priority Critical patent/SE519350C2/sv
Publication of SE9700244D0 publication Critical patent/SE9700244D0/sv
Priority to EP98850012A priority patent/EP0856519A3/en
Priority to CA002221793A priority patent/CA2221793C/en
Priority to US09/014,574 priority patent/US6063765A/en
Publication of SE519350C2 publication Critical patent/SE519350C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43586—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from silkworms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
SE9700244A 1997-01-28 1997-01-28 Antibakteriellt protein med specifik effekt mot gram-negativa bakterier, farmaceutiskt aktiva fragment därav med samma specifika effekt, samt farmaceutisk komposition innehållande proteinet eller fragment därav SE519350C2 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9700244A SE519350C2 (sv) 1997-01-28 1997-01-28 Antibakteriellt protein med specifik effekt mot gram-negativa bakterier, farmaceutiskt aktiva fragment därav med samma specifika effekt, samt farmaceutisk komposition innehållande proteinet eller fragment därav
EP98850012A EP0856519A3 (en) 1997-01-28 1998-01-21 Antibacterial insect protein
CA002221793A CA2221793C (en) 1997-01-28 1998-01-27 Novel antibacterial protein
US09/014,574 US6063765A (en) 1997-01-28 1998-01-28 Antibacterial protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700244A SE519350C2 (sv) 1997-01-28 1997-01-28 Antibakteriellt protein med specifik effekt mot gram-negativa bakterier, farmaceutiskt aktiva fragment därav med samma specifika effekt, samt farmaceutisk komposition innehållande proteinet eller fragment därav

Publications (2)

Publication Number Publication Date
SE9700244D0 true SE9700244D0 (sv) 1997-01-28
SE519350C2 SE519350C2 (sv) 2003-02-18

Family

ID=20405546

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700244A SE519350C2 (sv) 1997-01-28 1997-01-28 Antibakteriellt protein med specifik effekt mot gram-negativa bakterier, farmaceutiskt aktiva fragment därav med samma specifika effekt, samt farmaceutisk komposition innehållande proteinet eller fragment därav

Country Status (4)

Country Link
US (1) US6063765A (sv)
EP (1) EP0856519A3 (sv)
CA (1) CA2221793C (sv)
SE (1) SE519350C2 (sv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE519350C2 (sv) * 1997-01-28 2003-02-18 Anette Carlsson Antibakteriellt protein med specifik effekt mot gram-negativa bakterier, farmaceutiskt aktiva fragment därav med samma specifika effekt, samt farmaceutisk komposition innehållande proteinet eller fragment därav
EP1006124B1 (en) * 1998-12-02 2006-09-13 Entopharm Co., Ltd. Immunomodulatory materials from Calliphora vicina larvae, their preparation and use
RU2172322C1 (ru) 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды
US20040028651A1 (en) * 2001-03-29 2004-02-12 Karrupiah Muthumani Composition and methods of using hiv vpr
US20050042202A1 (en) * 2001-10-05 2005-02-24 Weiner David B. Compositions for and methods of treating and preventing sirs/sepsis
WO2011041483A2 (en) 2009-09-30 2011-04-07 Toxcure, Inc. Use of botulinum neurotoxin to treat substance addictions
CN107727436B (zh) * 2017-10-18 2020-08-21 太原师范学院 一种小型昆虫血淋巴收集方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE519350C2 (sv) * 1997-01-28 2003-02-18 Anette Carlsson Antibakteriellt protein med specifik effekt mot gram-negativa bakterier, farmaceutiskt aktiva fragment därav med samma specifika effekt, samt farmaceutisk komposition innehållande proteinet eller fragment därav

Also Published As

Publication number Publication date
EP0856519A2 (en) 1998-08-05
CA2221793C (en) 2002-07-09
SE519350C2 (sv) 2003-02-18
CA2221793A1 (en) 1998-07-28
US6063765A (en) 2000-05-16
EP0856519A3 (en) 1999-12-15

Similar Documents

Publication Publication Date Title
NO20014507L (no) Legemiddel for behandling av sukkersyke
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
ATE218581T1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
LU90969I2 (fr) Compositions ophtalmiques topiques contenant olopatadine destinees au tritement d'affections allergiques des yeux
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
MX9702531A (es) Compuesto nuevo.
BG101118A (en) Therapeutical compounds
DE69529670D1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
FR2762843B1 (fr) Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
EA200100700A1 (ru) Гены и белки и их применение
SE9700244D0 (sv) Novel antibacterial protein
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
BRPI0413682A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
BRPI0413684A (pt) compostos, composição farmacêutica e respectivos métodos de preparação, de tratamento de infecção microbiana e de extermìnio de microrganismo e usos
HUP0000110A2 (hu) Azaciklusos, azabiciklusos vagy tetrahidropiridinszármazékokat tartalmazó, fájdalom kezelésére alkalmas gyógyászati készítmények
ATE258229T1 (de) Substanz fa-70d, herstellungsverfahren und verwendungen
EA200100701A1 (ru) Белки наружной поверхности, их гены и их применение
BR0112123A (pt) Composto
FI961505A0 (sv) Nya peptidföreningar, som är terapeutiskt aktiva i blodkoaguleringssystem, förfarande för deras framställning och farmaceutiska kompositioner, som innehåller dem
BR0013741A (pt) Composto, processo para a preparação de um composto, medicamento, agente terapêutico ou profilático para doenças infecciosas fúngicas, cepa, uso de um composto, método para o tratamento ou a prevenção de uma infecção fúngica, e, composição farmacêutica
EA199800941A1 (ru) Терапевтические средства, содержащие кислородные анион-радикалы и/или продукты их последующего превращения и расщепления, и их применение для лечения болезни паркинсона
ATE212839T1 (de) Hämoregulatorische verbindungen
WO1998014567A3 (en) Methods and compositions for inhibiting bacterial growth

Legal Events

Date Code Title Description
NUG Patent has lapsed